Janus Henderson Group PLC Neurocrine Biosciences Inc Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 971,203 shares of NBIX stock, worth $123 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
971,203
Previous 1,378,513
29.55%
Holding current value
$123 Million
Previous $190 Million
29.67%
% of portfolio
0.07%
Previous 0.11%
Shares
29 transactions
Others Institutions Holding NBIX
# of Institutions
625Shares Held
94.7MCall Options Held
642KPut Options Held
288K-
Black Rock Inc. New York, NY14.2MShares$1.8 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.28 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$585 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$313 Million0.6% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.9MShares$241 Million4.37% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...